CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Cincinnati, Ohio, United States and 224 other locations
vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...
Phase 3
Cincinnati, Ohio, United States and 192 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Cincinnati, Ohio, United States and 305 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib \[AZD1775\]) in second or third line setting in patients with Triple...
Phase 2
Cincinnati, Ohio, United States and 140 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Cincinnati, Ohio, United States and 258 other locations
including metastatic colorectal cancer (mCRC) patients....
Phase 1
Cincinnati, Ohio, United States and 38 other locations
pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of JANX008 in adult subjects with advanced or metastatic c...
Phase 1
Cincinnati, Ohio, United States and 15 other locations
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers...
Phase 1, Phase 2
Cincinatti, Ohio, United States and 12 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...
Phase 1
Kettering, Ohio, United States and 123 other locations
farletuzumab ecteribulin (MORAb-202) in participants with selected tumor types (ovarian cancer \[OC\], endometrial cancer -...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 53 other locations
Clinical trials
Research sites
Resources
Legal